We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2012 by Innovative Medical.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01382810
First Posted: June 27, 2011
Last Update Posted: June 14, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Innovative Medical
  Purpose
The purpose of this study is to evaluate and compare the effects of Altaire Gel forming solution and Refresh Tears in mild-moderate dry eye patients.

Condition Intervention Phase
Dry Eye Syndromes Drug: Altaire Gel forming solution Drug: Refresh Tears Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

Primary Outcome Measures:
  • TBUT [ Time Frame: 2 months ]
    Test performed that measures how long the tears take to break up

  • Conjunctival and Corneal staining [ Time Frame: 2 months ]
    Dye that will be placed inside the eye to evaluate the surface of the ey


Estimated Enrollment: 100
Study Start Date: March 2011
Estimated Study Completion Date: October 2012
Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Altaire Gel forming solution Drug: Altaire Gel forming solution
Three times a day for two months
Placebo Comparator: Refresh Tears Drug: Refresh Tears
Three times a day for two months

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients 18 years or older.
  • Males or females.
  • Patient reported dry eye symptoms (episodic, annoying, activity limiting).
  • Physician assessment of mild-moderate dry eye.
  • Patient willing to instill drops TID and complete entire length of protocol.
  • TBUT _< 10 seconds.
  • At least Grade 6 Corneal Staining.

Exclusion Criteria:

  • Current topical cyclosporine use (Restasis)
  • Current Refresh use.
  • Refractive surgery within the last 6 months.
  • Oral or topical corticosteroid use.
  • Severe dry eye patients by physician assessment.
  • Current active blepharitis.
  • Oral doxycycline use.
  • Oral antihistamine use.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01382810


Contacts
Contact: Jenna Piel 951-653-5566 j.piel@imedsonline.com

Locations
United States, Illinois
Jackson Eye, SC Recruiting
Lake Villa, Illinois, United States
Contact: Annie Christensen    951-653-5566    a.christensen@imedsonline.com   
Principal Investigator: Mitch Jackson, MD         
United States, Rhode Island
Koch Eye Associates Recruiting
Warwick, Rhode Island, United States
Contact: Annie Christensen    951-653-5566    a.christensen@imedsonline.com   
Principal Investigator: Paul Koch, MD         
Sponsors and Collaborators
Innovative Medical
  More Information

Responsible Party: Melissa Earl, CRO
ClinicalTrials.gov Identifier: NCT01382810     History of Changes
Other Study ID Numbers: Altaire2011
First Submitted: June 24, 2011
First Posted: June 27, 2011
Last Update Posted: June 14, 2012
Last Verified: June 2012

Keywords provided by Innovative Medical:
dry eye signs and symptoms

Additional relevant MeSH terms:
Keratoconjunctivitis Sicca
Dry Eye Syndromes
Signs and Symptoms
Keratoconjunctivitis
Conjunctivitis
Conjunctival Diseases
Eye Diseases
Keratitis
Corneal Diseases
Lacrimal Apparatus Diseases
Pharmaceutical Solutions